← Leaderboards
Edward Wong
$870,035
Attributed
$870,035
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $406K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$870,035 · 1
By mechanism
N02$870,035 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,375,181
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,483,553
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,555,721
- Yunda Huang · Fred Hutchinson Cancer Center$54,118,126
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Biological MarkersBlood Coagulation DisordersCancer PatientCovid-19LaboratoriesNational Cancer InstituteNatural HistoryScience
Grant awards (3)
Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Instituteâs COVID-19 in Cancer Patients Study (NCCAPS)$155,897
N02 · FY2023 · CA · contact PI
Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Instituteâs COVID-19 in Cancer Patients Study (NCCAPS)$308,144
N02 · FY2022 · CA · contact PI
Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Instituteâs COVID-19 in Cancer Patients Study (NCCAPS)$405,994
N02 · FY2021 · CA · contact PI